Cargando…
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells
Overcoming the resistance of tumours to chemotherapy, often due to downregulation of Bax and Bak, represents a significant clinical challenge. It is therefore important to identify novel apoptosis inducers that bypass Bax and Bak. Potassium channels are emerging as oncological targets and a crucial...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407946/ https://www.ncbi.nlm.nih.gov/pubmed/22496117 http://dx.doi.org/10.1002/emmm.201200235 |
_version_ | 1782239413298790400 |
---|---|
author | Leanza, Luigi Henry, Brian Sassi, Nicola Zoratti, Mario Chandy, K George Gulbins, Erich Szabò, Ildikò |
author_facet | Leanza, Luigi Henry, Brian Sassi, Nicola Zoratti, Mario Chandy, K George Gulbins, Erich Szabò, Ildikò |
author_sort | Leanza, Luigi |
collection | PubMed |
description | Overcoming the resistance of tumours to chemotherapy, often due to downregulation of Bax and Bak, represents a significant clinical challenge. It is therefore important to identify novel apoptosis inducers that bypass Bax and Bak. Potassium channels are emerging as oncological targets and a crucial role of mitochondrial Kv1.3 in apoptosis has been demonstrated. Here we report for the first time that Psora-4, PAP-1 and clofazimine, three distinct membrane-permeant inhibitors of Kv1.3, induce death by directly targeting the mitochondrial channel in multiple human and mouse cancer cell lines. Importantly, these drugs activated the intrinsic apoptotic pathway also in the absence of Bax and Bak, a result in agreement with the current mechanistic model for mitochondrial Kv1.3 action. Genetic deficiency or short interfering RNA (siRNA)-mediated downregulation of Kv1.3 abrogated the effects of the drugs. Intraperitoneal injection of clofazimine reduced tumour size by 90% in an orthotopic melanoma B16F10 mouse model in vivo, while no adverse effects were observed in several healthy tissues. The study indicates that inhibition of mitochondrial Kv1.3 might be a novel therapeutic option for the induction of cancer cell death independent of Bax and Bak. |
format | Online Article Text |
id | pubmed-3407946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | WILEY-VCH Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-34079462012-09-17 Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells Leanza, Luigi Henry, Brian Sassi, Nicola Zoratti, Mario Chandy, K George Gulbins, Erich Szabò, Ildikò EMBO Mol Med Research Articles Overcoming the resistance of tumours to chemotherapy, often due to downregulation of Bax and Bak, represents a significant clinical challenge. It is therefore important to identify novel apoptosis inducers that bypass Bax and Bak. Potassium channels are emerging as oncological targets and a crucial role of mitochondrial Kv1.3 in apoptosis has been demonstrated. Here we report for the first time that Psora-4, PAP-1 and clofazimine, three distinct membrane-permeant inhibitors of Kv1.3, induce death by directly targeting the mitochondrial channel in multiple human and mouse cancer cell lines. Importantly, these drugs activated the intrinsic apoptotic pathway also in the absence of Bax and Bak, a result in agreement with the current mechanistic model for mitochondrial Kv1.3 action. Genetic deficiency or short interfering RNA (siRNA)-mediated downregulation of Kv1.3 abrogated the effects of the drugs. Intraperitoneal injection of clofazimine reduced tumour size by 90% in an orthotopic melanoma B16F10 mouse model in vivo, while no adverse effects were observed in several healthy tissues. The study indicates that inhibition of mitochondrial Kv1.3 might be a novel therapeutic option for the induction of cancer cell death independent of Bax and Bak. WILEY-VCH Verlag 2012-07 2012-04-11 /pmc/articles/PMC3407946/ /pubmed/22496117 http://dx.doi.org/10.1002/emmm.201200235 Text en Copyright © 2012 EMBO Molecular Medicine |
spellingShingle | Research Articles Leanza, Luigi Henry, Brian Sassi, Nicola Zoratti, Mario Chandy, K George Gulbins, Erich Szabò, Ildikò Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells |
title | Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells |
title_full | Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells |
title_fullStr | Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells |
title_full_unstemmed | Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells |
title_short | Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cells |
title_sort | inhibitors of mitochondrial kv1.3 channels induce bax/bak-independent death of cancer cells |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407946/ https://www.ncbi.nlm.nih.gov/pubmed/22496117 http://dx.doi.org/10.1002/emmm.201200235 |
work_keys_str_mv | AT leanzaluigi inhibitorsofmitochondrialkv13channelsinducebaxbakindependentdeathofcancercells AT henrybrian inhibitorsofmitochondrialkv13channelsinducebaxbakindependentdeathofcancercells AT sassinicola inhibitorsofmitochondrialkv13channelsinducebaxbakindependentdeathofcancercells AT zorattimario inhibitorsofmitochondrialkv13channelsinducebaxbakindependentdeathofcancercells AT chandykgeorge inhibitorsofmitochondrialkv13channelsinducebaxbakindependentdeathofcancercells AT gulbinserich inhibitorsofmitochondrialkv13channelsinducebaxbakindependentdeathofcancercells AT szaboildiko inhibitorsofmitochondrialkv13channelsinducebaxbakindependentdeathofcancercells |